DADA Consultancy
Mastering Regulatory Compliance Across the Product Journey

During a simpler era in regulatory history, registering a generic medicine required little more than a two-page document with basic biomedical details. But as the healthcare landscape matured, so too have its regulations, evolving into sophisticated frameworks designed to ensure patient safety and product efficacy.

For DADA Consultancy, this evolution has been more than just a shift. It has been a catalyst for an effort to turn complex regulatory demands into patient-focused solutions.

“We see regulatory challenges as opportunities to drive innovation and deliver value,” explains Angela van der Salm, managing partner. “When clients bring us their most complex problems, our elite team, including pharmacovigilance, regulatory affairs, toxicology and scientific writing experts don’t just provide solutions-they craft strategies that move them ahead of the curve.”

Each challenge becomes a shared opportunity to strengthen the bonds between DADA and its clients. From developing forward-thinking pharmacovigilance strategies to designing safety monitoring frameworks, DADA transforms potential setbacks into stepping stones, ensuring clients are always ready for what’s next.

The results speak for themselves. A client partnership began with a straightforward request to conduct local file assessments in the Netherlands. DADA quickly earned the client’s trust by delivering exceptional service in this initial engagement, prompting additional requests for Polish-language document reviews.

Then came a bold new challenge. The client sought assistance with electronic common technical document (eCTD) sequences for the U.S. market, a comparatively nascent service offered by only a limited number of providers at the time. Rather than shy away, the company invested in training and resources to master the process and delivered flawlessly. What started as a one-off request became a core capability, exemplifying DADA’s ability to learn, adapt and deliver for its clients.

By embracing the complexities of modern regulations and working collaboratively with clients, DADA’s strategic partnership enables businesses to thrive in a demanding and dynamic industry. It proves that the right perspective can turn even the most complex challenges into gateways to growth.

A Partner for Patient Safety

Safety and efficacy lie at the heart of its pharmacovigilance services, forming the foundation of its comprehensive solutions.

Trusted by clients worldwide, DADA handles every facet of pharmacovigilance-from managing a safety database to ensuring compliance with ever-evolving regulatory standards. By delivering turnkey solutions, it minimises risk and guarantees clients regulatory compliance.

The value of partnering with DADA becomes apparent from the outset. During early-stage collaborations, its experts become an extension of the client’s team, providing actionable insights that shape study designs and streamline regulatory submissions. Addressing potential safety concerns at this critical stage ensures products are primed to meet the industry’s highest safety standards.

As products enter the market, a dedicated pharmacovigilance team steps in to oversee ongoing safety monitoring. A proactive approach protects patients while reinforcing trust in the client’s brand, creating a lasting competitive advantage in the marketplace.

“While we understand clients may want quick or cost-effective solutions, we always advocate for the highest safety standards to protect patients. That’s a responsibility we uphold firmly,” says Radek Szymczak, senior manager of regulatory affairs. “This patient-first philosophy inevitably empowers clients to meet their regulatory responsibilities with confidence and ease.”

Such a proactive mindset extends beyond compliance, as it embraces the forward-thinking approach to anticipating client needs. By staying ahead of legislative changes and industry advancements, the team delivers solutions tailored to emerging challenges. This was exemplified in its swift response to the European Union’s Identification of Medicinal Products (IDMP) requirements. Recognising the significance of these regulations, DADA established a specialised cross-functional project team, enabling clients to navigate new standards with precision and readiness.

Prioritising both sides of the coin-patient safety and regulatory excellence-DADA addresses today’s challenges while equipping clients to thrive in an ever-evolving industry landscape.

A Reputation Built on Trust and Quality

Trust is the currency of the regulatory world, and DADA has spent years earning it, project by project, client by client. What begins as a client’s search for targeted support often evolves into something much deeper-a long-term partnership grounded in reliability. Such commitment is woven into the company’s values and reflected through its ISO 9001 certification, ensuring it consistently delivers the quality and superior results its clients deserve.

Local authorities and global organisations alike recognise DADA as a mark of integrity, expertise and excellence. But what sets it apart is how it is deeply embedded in every stage of a product’s lifecycle-from development to market readiness. Consider its recent expansion into marketing and compliance services. In response to the growing demands of frameworks like the “Code of Medicinal Promotion” in the Netherlands, DADA stepped up, integrating new capabilities seamlessly into its repertoire. Clients can confidently navigate complex promotional guidelines while maintaining full regulatory compliance. By aligning marketing strategies with industry standards, DADA will help mitigate risks while enhancing the credibility and market success of its clients’ products.

In an industry where the stakes are high and the margins for error are slim, DADA Consultancy has built something rare-a reputation not just for delivering results, but for redefining what success looks like in regulatory affairs.